SCHEMBL1633063

SCHEMBL1633063

NS(=O)(=O)c1ccc(Nc2ncc3cccc(CN4CCc5ccccc5C4)c3n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 6/20 0.53
▸ MAPK1 P28482 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ DHFR P00374 1/20 0.44
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CDK2 P24941 2/20 0.42
▸ CCNE1 P24864 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ PRMT5 O14744 1/20 0.42
▸ WDR77 Q9BQA1 1/20 0.42
▸ CCNT1 O60563 2/20 0.41
▸ CDK1 P06493 2/20 0.41
▸ CCNB1 P14635 2/20 0.41
▸ CDK7 P50613 2/20 0.41
▸ CDK9 P50750 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633835 0.85 IKBKB (0.47) IKBKBCA1CA2CA9CA12
SCHEMBL1633031 0.85 FGFR4 (0.47) IKBKBCA1CA2CA9CDK2
SCHEMBL1632397 0.83 TBK1 (0.57) IKBKBCA1CA2CA9CA12
SCHEMBL1632711 0.83 CA2 (0.46) IKBKBCA1CA2CA9CDK2
SCHEMBL1632154 0.80 CDK2 (0.46) IKBKBCA1CA2CA9CA12
SCHEMBL1631354 0.80 TYK2 (0.54) IKBKBCA1CA2CA9CA12
SCHEMBL1633709 0.79 SYK (0.47) IKBKBCA2CDK2CCNE1CCNT1
SCHEMBL1633356 0.78 CDK1 (0.44) IKBKBCA2CDK2CDK1CDK9
SCHEMBL1633514 0.78 CDK1 (0.44) IKBKBCA2CDK2CDK1CDK9
SCHEMBL1633354 0.78 CDK1 (0.44) IKBKBCA2CDK2CDK1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback